[go: up one dir, main page]

HUE037994T2 - Készítmények és eljárások szennyezõ anyagok, testfolyadékok vagy más anyagok mozgásának befolyásolására és/vagy más fiziológiai állapotok befolyásolására - Google Patents

Készítmények és eljárások szennyezõ anyagok, testfolyadékok vagy más anyagok mozgásának befolyásolására és/vagy más fiziológiai állapotok befolyásolására

Info

Publication number
HUE037994T2
HUE037994T2 HUE07809027A HUE07809027A HUE037994T2 HU E037994 T2 HUE037994 T2 HU E037994T2 HU E07809027 A HUE07809027 A HU E07809027A HU E07809027 A HUE07809027 A HU E07809027A HU E037994 T2 HUE037994 T2 HU E037994T2
Authority
HU
Hungary
Prior art keywords
affecting
contaminants
entities
compositions
methods
Prior art date
Application number
HUE07809027A
Other languages
English (en)
Inventor
Rutledge Ellis-Behnke
Yu-Xiang Liang
Gerald Schneider
Kwok-Fai So
David Tay
Original Assignee
Massachusetts Inst Technology
Versitech Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Massachusetts Inst Technology, Versitech Ltd filed Critical Massachusetts Inst Technology
Publication of HUE037994T2 publication Critical patent/HUE037994T2/hu

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/10—Peptides having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0061—Use of materials characterised by their function or physical properties
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/42—Use of materials characterised by their function or physical properties
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
    • A61L2300/252—Polypeptides, proteins, e.g. glycoproteins, lipoproteins, cytokines

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Materials Engineering (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pain & Pain Management (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Diabetes (AREA)
  • Dermatology (AREA)
  • Materials For Medical Uses (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
HUE07809027A 2006-04-25 2007-04-25 Készítmények és eljárások szennyezõ anyagok, testfolyadékok vagy más anyagok mozgásának befolyásolására és/vagy más fiziológiai állapotok befolyásolására HUE037994T2 (hu)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US74560106P 2006-04-25 2006-04-25

Publications (1)

Publication Number Publication Date
HUE037994T2 true HUE037994T2 (hu) 2018-09-28

Family

ID=38458016

Family Applications (1)

Application Number Title Priority Date Filing Date
HUE07809027A HUE037994T2 (hu) 2006-04-25 2007-04-25 Készítmények és eljárások szennyezõ anyagok, testfolyadékok vagy más anyagok mozgásának befolyásolására és/vagy más fiziológiai állapotok befolyásolására

Country Status (12)

Country Link
US (3) US9084837B2 (hu)
EP (1) EP2012842B1 (hu)
JP (1) JP2009535338A (hu)
KR (2) KR20110091019A (hu)
CN (1) CN101472620A (hu)
AU (1) AU2007257425A1 (hu)
CA (1) CA2650230C (hu)
DK (1) DK2012842T3 (hu)
ES (1) ES2673947T3 (hu)
HU (1) HUE037994T2 (hu)
IL (1) IL194831A (hu)
WO (1) WO2007142757A2 (hu)

Families Citing this family (52)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7220276B1 (en) * 2000-03-06 2007-05-22 Surmodics, Inc. Endovascular graft coatings
JP5183068B2 (ja) * 2003-12-22 2013-04-17 フィンレイ，ウォーレン，エイチ 大気噴出凍結乾燥法による粉末形成
US9162005B2 (en) * 2005-04-25 2015-10-20 Arch Biosurgery, Inc. Compositions for prevention of adhesions and other barrier applications
AU2006241123B2 (en) 2005-04-25 2013-10-03 Massachusetts Institute Of Technology Compositions and methods for promoting hemostasis and other physiological activities
CN101472620A (zh) 2006-04-25 2009-07-01 麻省理工学院 用于影响污染物、机体流体或其它实体移动和/或影响其它生理状况的组合物和方法
EP2146733B1 (en) 2007-03-14 2020-11-25 Arch Biosurgery, Inc. Treatment of leaky or damaged tight junctions and enhancing extracellular matrix
US7906478B2 (en) * 2007-07-20 2011-03-15 The Procter & Gamble Company Personal-care articles having self-assembling peptides
US8524796B2 (en) * 2008-08-13 2013-09-03 Dow Global Technologies Llc Active polymer compositions
ES2624484T3 (es) 2008-10-06 2017-07-14 3-D Matrix, Ltd. Tapón de tejido
US20110054326A1 (en) * 2009-06-19 2011-03-03 Vanderbilt University Direct visualization catheter
US20110047671A1 (en) * 2009-08-27 2011-03-03 Zhu Yuan-Shan Antibacterial and antiviral glove
US9439941B2 (en) 2009-12-14 2016-09-13 The University Of Hong Kong Nano cancer barrier device (NCBD) to immobilize and inhibit the division of metastic cancer stem cells
US20110143993A1 (en) * 2009-12-15 2011-06-16 The Brigham And Women's Hospital, Inc. Endothelial basement membrane targeting peptide ligands
US9402863B2 (en) * 2010-03-05 2016-08-02 Endosat Nv Methods and systems for conditioning in surgery
JP5580670B2 (ja) * 2010-06-29 2014-08-27 花王株式会社 ナノファイバ積層シート
US9125811B2 (en) 2010-06-29 2015-09-08 Kao Corporation Nanofiber laminate sheet
US8515525B2 (en) 2011-08-16 2013-08-20 Women's Imaging Solutions Enterprises Llc Skin adhesive agent for mammography procedures
CN102408575B (zh) * 2011-09-09 2013-02-13 南京大学 一种可注射多肽水凝胶的制备方法
CN102989034B (zh) * 2011-09-10 2016-01-20 温州医学院 一种应用于神经吻合术的水凝胶及其制备方法
US9204801B2 (en) * 2011-11-21 2015-12-08 Kci Licensing, Inc. Systems, devices, and methods for identifying portions of a wound filler left at a tissue site
WO2013123491A1 (en) 2012-02-17 2013-08-22 Massachusetts Institute Of Technology Self-regulated peptide hydrogel for insulin delivery
EP3466964A1 (en) 2012-07-06 2019-04-10 3-D Matrix Ltd. Fill-finish process for peptide solutions
CA2878680C (en) 2012-07-23 2019-09-17 Crayola, Llc Dissolvable films and methods of using the same
KR101432276B1 (ko) * 2013-02-06 2014-08-21 주식회사 이노테라피 총경동맥 또는 상시상 정맥동에 출혈이 유발된 지혈제 성능평가 동물모델 및 그 용도
DE102013211316A1 (de) * 2013-06-17 2014-12-18 Aesculap Ag Hämostyptikum
WO2015027203A1 (en) 2013-08-22 2015-02-26 Arch Biosurgery, Inc. Implantable meshes for controlling the movement of fluids
WO2015035189A1 (en) * 2013-09-06 2015-03-12 University Of Pittsburgh-Of The Commonwealth System Of Higher Education Material to prevent post surgical infection
US8877882B1 (en) * 2013-10-04 2014-11-04 Rochal Industries Llp Non-self-adherent coating materials
CN103665110B (zh) * 2013-12-06 2015-10-28 华南理工大学 半程电荷互补型手性自组装短肽纳米生物医药材料及应用
US20170173105A1 (en) * 2014-03-10 2017-06-22 3-D Matrix, Ltd. Autoassembling peptides for the treatment of pulmonary leakage
WO2015138514A1 (en) 2014-03-10 2015-09-17 3-D Matrix, Ltd. Self-assembling peptide compositions
JP6684719B2 (ja) 2014-03-10 2020-04-22 株式会社スリー・ディー・マトリックス ペプチド組成物の滅菌および濾過
US10245299B2 (en) 2014-03-10 2019-04-02 3-D Matrix, Ltd. Autoassembling peptides for the treatment of pulmonary bulla
JP6554121B2 (ja) * 2014-03-10 2019-07-31 株式会社スリー・ディー・マトリックス 気管支閉鎖剤としての自己組織化ペプチド
CN105664232B (zh) * 2015-12-30 2019-04-12 深圳清华大学研究院 止血材料及其制备方法和应用
WO2017120092A1 (en) 2016-01-06 2017-07-13 3-D Matrix, Ltd. Combination compositions
CN107029301A (zh) * 2016-02-04 2017-08-11 郑敦武 一种纳米自组装水凝胶在颅神经手术防粘连材料中的用途
CN107029300A (zh) * 2016-02-04 2017-08-11 郑敦武 一种纳米自组装水凝胶在手术防粘连材料中的用途
CN107029287A (zh) * 2016-02-04 2017-08-11 郑敦武 一种纳米自组装水凝胶在人工硬脑膜材料中的用途
BR112018068939A2 (pt) * 2016-03-18 2019-01-22 3 D Matrix Ltd oclusão de vazamento de fluido cérebro-espinhal
CN109562199A (zh) * 2016-06-01 2019-04-02 立美基股份有限公司 具有自组装肽水凝胶的止血粉末
US20200282100A1 (en) * 2016-06-01 2020-09-10 3-D Matrix, Ltd. Hemostatic Dressings with Self-Assembling Peptide Hydrogels
GB201713511D0 (en) 2017-08-23 2017-10-04 Scapa Uk Ltd Wound dressing
EP3723726A1 (en) 2017-12-15 2020-10-21 3-D Matrix, Ltd. Surfactant peptide nanostructures and uses in drug delivery
WO2019182905A1 (en) 2018-03-23 2019-09-26 Arch Biosurgery, Inc. Sap and peptidomimetics for treatment of eye disease
US20190292226A1 (en) 2018-03-23 2019-09-26 Arch Biosurgery, Inc. Sap and peptidomimetic compositions for reducing symptoms of inflammation
US11364022B2 (en) 2018-05-08 2022-06-21 Ithemba, LLC Reusable core needle biopsy device and disposable needle system to eliminate internal contamination risk in reusable portion of device
JP7437315B2 (ja) * 2018-10-05 2024-02-22 学校法人 久留米大学 腸管における潰瘍または瘻孔の治療または予防のための医薬組成物
US20220233209A1 (en) * 2019-08-02 2022-07-28 Thomas Julius Borody Colonic treatment methods and apparatus
WO2021146291A1 (en) 2020-01-13 2021-07-22 Arch Biosurgery, Inc. Self-assembling peptide gel formulation and methods of use
CN113384743A (zh) * 2021-07-09 2021-09-14 吉林省国大生物工程有限公司 一种具有促进组织修复及抗菌的温敏敷料的制备方法
CN114414337B (zh) * 2022-01-21 2023-11-10 山东大学 一种基于dna凝胶的铅离子快速检测方法

Family Cites Families (68)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1006606A (en) 1961-05-12 1965-10-06 Fmc Corp Haemostatic wound dressing
US4098728A (en) * 1976-01-02 1978-07-04 Solomon Rosenblatt Medical surgical sponge and method of making same
US4211227A (en) * 1978-07-03 1980-07-08 The Kendall Company Surgical sponge material
US4272398A (en) * 1978-08-17 1981-06-09 The United States Of America As Represented By The Secretary Of Agriculture Microencapsulation process
US4636208A (en) * 1984-10-05 1987-01-13 Ewald Rath Surgical sponge
US4829000A (en) 1985-08-30 1989-05-09 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Reconstituted basement membrane complex with biological activity
US4861627A (en) * 1987-05-01 1989-08-29 Massachusetts Institute Of Technology Preparation of multiwall polymeric microcapsules
US5019646A (en) 1987-08-25 1991-05-28 Regents Of The University Of Minnesota Polypeptides with fibronectin activity
US5843156A (en) 1988-08-24 1998-12-01 Endoluminal Therapeutics, Inc. Local polymeric gel cellular therapy
US5126141A (en) * 1988-11-16 1992-06-30 Mediventures Incorporated Composition and method for post-surgical adhesion reduction with thermo-irreversible gels of polyoxyalkylene polymers and ionic polysaccharides
EP0609212A4 (en) * 1989-12-04 1995-04-19 Kensey Nash Corp PLUG DEVICE FOR SEALING OPENINGS AND METHOD FOR USE.
US5180375A (en) * 1991-05-02 1993-01-19 Feibus Miriam H Woven surgical drain and woven surgical sponge
US5222974A (en) * 1991-11-08 1993-06-29 Kensey Nash Corporation Hemostatic puncture closure system and method of use
JPH05204646A (ja) 1992-01-28 1993-08-13 Mitsubishi Electric Corp 知識処理システム
US5955343A (en) * 1992-12-28 1999-09-21 Massachusetts Institute Of Technology Stable macroscopic membranes formed by self-assembly of amphiphilic peptides and uses therefor
US5670483A (en) * 1992-12-28 1997-09-23 Massachusetts Insititute Of Technology Stable macroscopic membranes formed by self-assembly of amphiphilic peptides and uses therefor
FR2715309B1 (fr) 1994-01-24 1996-08-02 Imedex Composition adhésive, à usage chirurgical, à base de collagène modifié par coupure oxydative et non réticulé.
US6413539B1 (en) 1996-10-31 2002-07-02 Poly-Med, Inc. Hydrogel-forming, self-solvating absorbable polyester copolymers, and methods for use thereof
WO1996040033A1 (en) 1995-06-07 1996-12-19 Clarion Pharmaceuticals Inc. Non-biological patch for hemostasis
US5645565A (en) * 1995-06-13 1997-07-08 Ethicon Endo-Surgery, Inc. Surgical plug
AU726163B2 (en) 1996-04-04 2000-11-02 Baxter Healthcare Sa Hemostatic sponge based on collagen
US6489446B1 (en) 1996-08-07 2002-12-03 Hsc Research And Development Limited Partnership Self-aligning peptides modeled on human elastin and other fibrous proteins
US6177609B1 (en) 1997-03-10 2001-01-23 Meadox Medicals, Inc. Self-aggregating protein compositions and use as sealants
US5906997A (en) 1997-06-17 1999-05-25 Fzio Med, Inc. Bioresorbable compositions of carboxypolysaccharide polyether intermacromolecular complexes and methods for their use in reducing surgical adhesions
US6368877B1 (en) * 1997-06-25 2002-04-09 Massachusetts Institute Of Technology Self-assembling peptide surfaces for cell patterning and interactions
US6235340B1 (en) 1998-04-10 2001-05-22 Massachusetts Institute Of Technology Biopolymer-resistant coatings
JP4159682B2 (ja) 1998-12-22 2008-10-01 株式会社クラレ 止血材
AU3347000A (en) 1999-01-19 2000-08-01 Children's Hospital Of Philadelphia, The Hydrogel compositions for controlled delivery of virus vectors and methods of use thereof
WO2000063079A1 (en) * 1999-04-15 2000-10-26 Ultracell Medical Technologies Of Connecticut, Inc. Method for producing surgical sponge device and product thereof
JP4596341B2 (ja) 1999-11-11 2010-12-08 オリンパステルモバイオマテリアル株式会社 液体状創傷被覆材
US6844324B1 (en) * 1999-11-12 2005-01-18 Massachusetts Institute Of Technology Modular peptide mediated intracellular delivery system and uses therefore
WO2001053539A1 (en) * 2000-01-24 2001-07-26 Phylos, Inc. Sensitive, multiplexed diagnostic assays for protein analysis
DE60138020D1 (de) 2000-04-28 2009-04-30 Fziomed Inc Haemostatische zusammenstellung von polysäuren und polyalkylenoxyden und deren verwendungsmethoden
US6953656B2 (en) * 2000-07-14 2005-10-11 Massachusetts Institute Of Technology Direct, externally imposed control of polypeptides
US6953659B2 (en) * 2000-07-14 2005-10-11 Massachusetts Institute Of Technology Direct, externally imposed control of nucleic acids
US6846319B2 (en) * 2000-12-14 2005-01-25 Core Medical, Inc. Devices for sealing openings through tissue and apparatus and methods for delivering them
SI1343542T1 (en) 2001-01-25 2005-10-31 Nycomed Pharma As Carrier with solid fibrinogen and solid thrombin
US7449180B2 (en) * 2001-02-06 2008-11-11 John Kisiday Macroscopic scaffold containing amphiphilic peptides encapsulating cells
WO2002062969A2 (en) 2001-02-06 2002-08-15 Massachusetts Institute Of Technology Cellular reprogramming in peptide hydrogel and uses thereof
JP3838882B2 (ja) 2001-02-28 2006-10-25 株式会社Ｐｈｇ 温度応答性材料およびそれを含む組成物
JP2004535392A (ja) * 2001-05-04 2004-11-25 ザ スクリプス リサーチ インスティチュート 抗菌ペプチドおよび組成物
IL159156A0 (en) * 2001-06-22 2004-06-01 Millard Marsden Mershon A gel forming composition containing a polyacrylic acid
WO2003006043A1 (en) 2001-07-10 2003-01-23 Massachusetts Institute Of Technology Surfactant peptide nanostructures, and uses thereof
WO2003052117A2 (en) * 2001-09-19 2003-06-26 Massachusetts Institute Of Technology Methods and products related to non-viral transfection
JP2003252936A (ja) 2002-02-28 2003-09-10 Sentomedo:Kk 温度応答性材料及びそれを含む組成物
AU2003222167A1 (en) * 2002-04-02 2003-10-20 Northwestern University Peptide amphiphile solutions and self assembled peptide nanofiber networks
AU2003249606A1 (en) 2002-05-13 2003-12-02 Massachusetts Institute Of Technology Angiogenesis and cardiac tissue engineering with peptide hydrogels and related compositions and methods of use thereof
CA2387257C (en) * 2002-05-23 2009-07-28 Suncor Energy Inc. Static deaeration conditioner for processing of bitumen froth
GB0216286D0 (en) * 2002-07-15 2002-08-21 Univ Leeds Network
JP2005534697A (ja) * 2002-08-06 2005-11-17 エピックス ファーマシューティカルズ， インコーポレイテッド ペプチド凝集体
WO2004110964A2 (en) * 2003-06-16 2004-12-23 Nuevolution A/S Encoded molecules by translation (emt)
EP2711025A3 (en) * 2003-06-25 2014-09-10 Massachusetts Institute of Technology Self-assembling peptides incorporating modifications and methods of use thereof
US7713923B2 (en) * 2003-06-25 2010-05-11 Massachusetts Institute Of Technology Self-assembling peptides incorporating modifications and methods of use thereof
JP2005074079A (ja) 2003-09-02 2005-03-24 Masao Tanihara 止血材
US7846891B2 (en) * 2003-10-17 2010-12-07 Massachusetts Institute Of Technology Self-assembling peptides for regeneration and repair of neural tissue
EP4023240A1 (en) 2004-07-06 2022-07-06 3D Matrix, Inc. Purified amphiphilic peptide compositions and uses thereof
US7884185B2 (en) * 2004-07-28 2011-02-08 University Of Delaware Hydrogels and uses thereof
US8039258B2 (en) 2004-09-28 2011-10-18 Ethicon, Inc. Tissue-engineering scaffolds containing self-assembled-peptide hydrogels
WO2006047315A2 (en) * 2004-10-25 2006-05-04 The Brigham And Women's Hospital, Inc. Targeted delivery of biological factors using self-assembling peptide nanofibers
AU2005323062A1 (en) * 2005-01-04 2006-07-13 The Brigham And Women's Hospital, Inc. Sustained delivery of PDGF using self-assembling peptide nanofibers
AU2006241123B2 (en) * 2005-04-25 2013-10-03 Massachusetts Institute Of Technology Compositions and methods for promoting hemostasis and other physiological activities
US9162005B2 (en) 2005-04-25 2015-10-20 Arch Biosurgery, Inc. Compositions for prevention of adhesions and other barrier applications
CN101472620A (zh) 2006-04-25 2009-07-01 麻省理工学院 用于影响污染物、机体流体或其它实体移动和/或影响其它生理状况的组合物和方法
WO2007147002A2 (en) * 2006-06-13 2007-12-21 Wisconsin Alumni Research Foundation Beta-peptide lyotropic liquid crystals and methods of manufacture and use thereof
WO2008039483A2 (en) * 2006-09-26 2008-04-03 Massachusetts Institute Of Technology Modified self-assembling peptides
EP2146733B1 (en) 2007-03-14 2020-11-25 Arch Biosurgery, Inc. Treatment of leaky or damaged tight junctions and enhancing extracellular matrix
US20120085262A1 (en) 2010-08-26 2012-04-12 Freudenberg Forschungsdienste Kg Production of Highly Concentrated Solutions of Self-Assembling Proteins
US20150064255A1 (en) 2012-02-22 2015-03-05 Northwestern University Nanostructures for treating cancers and other conditions

Also Published As

Publication number Publication date
JP2009535338A (ja) 2009-10-01
CN101472620A (zh) 2009-07-01
IL194831A0 (en) 2009-08-03
CA2650230C (en) 2017-01-10
WO2007142757A2 (en) 2007-12-13
CA2650230A1 (en) 2007-12-13
EP2012842A2 (en) 2009-01-14
WO2007142757A3 (en) 2008-10-02
DK2012842T3 (en) 2018-05-28
KR20110091019A (ko) 2011-08-10
ES2673947T3 (es) 2018-06-26
US20150328279A1 (en) 2015-11-19
US20080091233A1 (en) 2008-04-17
US20170143788A1 (en) 2017-05-25
US9084837B2 (en) 2015-07-21
AU2007257425A1 (en) 2007-12-13
US10137166B2 (en) 2018-11-27
US9511113B2 (en) 2016-12-06
IL194831A (en) 2016-06-30
EP2012842B1 (en) 2018-04-04
KR20090015935A (ko) 2009-02-12

Similar Documents

Publication Publication Date Title
IL194831A0 (en) Compositions and methods for affecting movement of contaminants, bodily fluids or other entities and/or affecting other physiological conditions
PL3398606T3 (pl) Kompozycje otrzymane z mikroalg poprawiające zdrowie i wygląd skóry
AP2885A (en) Methods and compositions for improving plant health
EP1888765A4 (en) METHOD AND COMPOSITIONS FOR DIAGNOSIS OF VENOUS THROMBOEMBOLIC ILLNESSES
IL197425A0 (en) Health integration platform api
PT2583970E (pt) Certas entidades químicas, composições e métodos compreendendo imidazopirimidinas
PL2026828T3 (pl) Zastosowanie co najmniej jednego polifenolu do wspomagania zdrowia oczu
SI2079760T1 (sl) Sestavki in metode za zdravljenje okužb
ZA200900388B (en) Compositions and methods for the treatment of mucositis
IL192319A0 (en) Assessment of medical conditions
GB0909297D0 (en) Composition for the treatment of skin conditions
IL197766A0 (en) Use of oritavancin for the prevention and treatment of anthrax
EP2056830A4 (en) SPECIAL COMPOSITIONS FOR TREATMENT OR PREVENTION OF METABOLIC SYNDROME
EP2068902A4 (en) COMPOSITIONS DERIVED FROM TEA AND METHODS OF USING THE SAME TO IMPROVE CARDIOVASCULAR HEALTH CONDITION
EP2037746A4 (en) GREATEST OIL COMPOSITIONS AND MANUFACTURING METHOD THEREFOR
IL201119A0 (en) Methods and compositions of derivatives of probucol for the treatment of diabetes
IL245911A0 (en) Compositions and methods for increasing the level of blood platelets in humans
SI2583970T1 (sl) Določene kemijske enote, sestavki in postopki, ki obsegajo imidazopirimidine
GB0601950D0 (en) Compositions and methods of treating diabetes
GB0620695D0 (en) Composition and methods for the treatment of nurdegenerative disease
EP1962882A4 (en) COMPOSITIONS AND METHOD FOR TREATING DIABETES
WO2006081350A8 (en) Methods and compositions for the diagnosis and treatment of schizophrenia
GB0618309D0 (en) Compositions and methods for the treatment of disease
AU2012258383B9 (en) Certain medical entities, compositions, and methods
EP1886692A4 (en) MEANS FOR IMPROVING INSULIN RESISTANCE